针对家禽的空肠弯曲菌的 DNA 初免/蛋白加强疫苗方案。
A DNA prime/protein boost vaccine protocol developed against Campylobacter jejuni for poultry.
机构信息
GVB - Viral Genetics and Biosafety Unit, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Ploufragan, France; HQPAP - Unit of Hygiene and Quality of Poultry and Pork Products, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Ploufragan, France.
HQPAP - Unit of Hygiene and Quality of Poultry and Pork Products, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Ploufragan, France.
出版信息
Vaccine. 2018 Apr 12;36(16):2119-2125. doi: 10.1016/j.vaccine.2018.03.004. Epub 2018 Mar 16.
Vaccination of broilers is one of the potential ways to decrease Campylobacter intestinal loads and therefore may reduce human disease incidence. Despite many studies, no efficient vaccine is available yet. Using the reverse vaccinology strategy, we recently identified new vaccine candidates whose immune and protective capacities need to be evaluated in vivo. Therefore, the goal of the present study was to develop and evaluate an avian subunit vaccine protocol for poultry against Campylobacter jejuni. For this, flagellin was used as vaccine antigen candidate. A DNA prime/protein boost regimen was effective in inducing a massive protective immune response against C. jejuni in specific pathogen free Leghorn chickens. Contrastingly, the same vaccine regimen stimulated the production of antibodies against Campylobacter in conventional Ross broiler chickens harbouring maternally derived antibodies against Campylobacter, but not the control of C. jejuni colonization. These results highlight the strength of the vaccine protocol in inducing protective immunity and the significance of the avian strain and/or immune status in the induction of this response. Nevertheless, as such the vaccine protocol is not efficient in broilers to induce protection and has to be adapted; this has been done in one of our recent published work.
给肉鸡接种疫苗是降低空肠弯曲菌肠道负荷的潜在方法之一,因此可能会降低人类疾病的发病率。尽管进行了许多研究,但目前仍没有有效的疫苗。我们最近使用反向疫苗学策略,鉴定了一些新的疫苗候选物,需要在体内评估它们的免疫和保护能力。因此,本研究的目的是为家禽开发和评估针对空肠弯曲菌的禽用亚单位疫苗方案。为此,我们使用鞭毛蛋白作为疫苗抗原候选物。在无特定病原体的来亨鸡中,DNA 初免/蛋白加强免疫方案可有效诱导针对空肠弯曲菌的大量保护性免疫反应。相比之下,相同的疫苗方案刺激了常规罗斯肉鸡产生针对弯曲菌的抗体,而这些鸡携带了针对弯曲菌的母源抗体,却不能控制空肠弯曲菌的定植。这些结果突出了疫苗方案在诱导保护性免疫方面的优势,以及禽种和/或免疫状态在诱导这种反应中的重要性。然而,由于该疫苗方案在诱导肉鸡的保护方面效率不高,因此需要进行调整;我们最近的一项已发表的工作已经对此进行了调整。